Work

Combinational CAR T-cell therapy for solid tumors: Requisites, rationales, and trials

Year: 2024

Type: article

Source: Pharmacology & Therapeutics

DOI: 10.1016/j.pharmthera.2024.108763

Authors: Kyohei Misawa, Hina Bhat, Prasad S. Adusumilli, Zhaohua Hou

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Joanne and John Dallepezze Foundation, U.S. Department of Defense, Novocure, National Institutes of Health, National Cancer Institute

Awards: G1440843596, G1725776530, The EDRN Mesothelioma Biomarker Discovery Laboratory, G2272812018, G311372582, G333081973, Tuning KITv CAR T cells for the solid tumor environment, G6021164154, G8790735321, G9000046383, G9000140850, Cancer Center Support Grant, CD28-KITv CAR T cells with PD-1 dominant negative receptor

OpenAlex ID: W4404851740

FWCI: 2.751

Cites: 101

Cited by: 18

Related to: 10